Gene Query: SHOC2

Dataset Description Geneva Score
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 43.82
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 43.82
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 37.37
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 37.37
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 28.94
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 26.55
Triple vectors expand AAV transfer capacity in the retina 25.71
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 23.81
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 20.69
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 17.96
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 17.91
Human cell line and subcutaneous tumor 17.8
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 17.61
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 17.59
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 17.18
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 16.81
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 16.53
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 16.53
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 16.41
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 15.48
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 15.48
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 15.37
Overexpression of NFIB and YBX1 in MCF-7 cells 14.9
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 14.89
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 14.53
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 14.48
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 13.97
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 13.55
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 13.55
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 13.35
IDH3a KO RNA-seq 13.35
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 12.88
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 12.73
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 12.6
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 12.57
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 11.98
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 11.98
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.87
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 11.71
RNA sequencing of primary human platelets and in vitro cell lines 11.64
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 11.64
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 11.51
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 11.42
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 11.41
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 11.39
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 11.36
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 11.36
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 11.17
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 11.06
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 11.0
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 10.98
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 10.91
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 10.84
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 10.73
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 10.47
SRSF2 mutations impair hematopoiesis and alter exon recognition 10.4
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 10.38
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 10.34
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 10.27
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 10.13
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 10.1
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 10.1
Genome wide expression change in LCC2 and MCF-7 cells 10.01
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 9.98
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 9.96
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 9.77
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 9.76
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 9.76
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 9.75
LncRNA expression profiling of ischemic stroke patients 9.72
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 9.63
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 9.63
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 9.59
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 9.44
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 9.43
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 9.43
RNAseq analysis of ESRP regulated splicing events in prostate cancer 9.27
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 9.2
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 9.2
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 9.19
Seletive inhibition of CDK9 in DLBCL cell lines 9.15
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 9.11
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 9.09
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 9.06
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 9.0
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 8.86
Effect of ILF3 on translation during homeostasis and the antiviral response 8.84
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 8.76
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 8.73
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 8.72
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 8.67
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 8.63
Transcriptional profiling of LS1034 cells treated with tepoxalin 8.61
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 8.59
Hijacking of stress response machinery by oncogenes in acute leukaemia 8.59
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 8.52
Identification of the role of polydom in neurofibromas 8.47
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 8.45
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 8.33
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 8.33
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 8.31
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 8.31
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 8.27
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 8.16
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 8.09
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 8.09
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.04
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 7.95
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 7.88
7.88
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 7.87
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.81
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 7.8
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 7.8
The comparison of high-throughput single-cell RNA-seq methods 7.8
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 7.78
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 7.71
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 7.68
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 7.68
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 7.64
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 7.64
WRN knockout effects upon gene expression in SW48 and OVK18 7.58
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 7.58
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 7.58
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 7.57
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 7.55
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 7.54
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 7.52
MYCi975 regulates MYC target genes 7.48
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 7.48
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 7.35
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 7.32
Effect of mitochondria deficiency on senescence-associated gene expression 7.3
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.3
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 7.25
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 7.19
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 7.16
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 7.15
Genome-wide analysis of the Integrator complex (HTS) 7.13
Genome-wide analysis of the Integrator complex 7.13
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 7.13
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.12
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 7.04
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 7.02
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 7.02
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 6.94
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 6.93
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 6.86
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 6.83
MYCL and EP400 are required for Max and MCPyV mediated gene activation 6.82
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 6.81
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 6.79
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 6.78
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 6.77
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 6.77
SLIGRL-induced gene expression changes in NHEK cells 6.75
DART-seq: an antibody-free method for global m6A detection 6.75
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 6.74
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 6.73
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 6.67
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 6.61
RNA-seq analysis of AML cells in response to ASLAN003 6.56
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 6.52
RNA expression analysis upon JMJD1C depletion 6.52
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 6.52
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 6.49
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 6.49
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 6.48
m6A-dependent regulation of messenger RNA stability 6.43
Transcriptomic analyssis following EHMT1/2 inhibition 6.39
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 6.36
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 6.36
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 6.35
RNA-seq analysis to identify the genes regulated by p53-SET interplay 6.3
Gene expression profiling of leukemia cells following asparagine depletion 6.3
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.27
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 6.27
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 6.27
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.25
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 6.25
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 6.2
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 6.2
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 6.19
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 6.19
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 6.19
The evolution of N6-methyladenosine in primates 6.17
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 6.15
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 6.14
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 6.14
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 6.1
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 6.09
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 6.08
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 6.08
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 6.04
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 6.02
The interplay between SOX4 and SMAD3 in the context of breast cancer 5.99
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 5.99
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 5.96
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 5.95
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 5.91
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 5.91
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 5.9
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 5.8
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 5.77
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 5.76
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 5.67
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 5.66
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 5.63
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 5.63
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 5.57
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 5.56
Electronic cigarettes 5.55
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 5.55
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 5.5
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 5.46
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 5.45
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 5.43
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 5.43
The contribution of Alu exons to the human proteome 5.37
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 5.35
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.34
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.34
single cell RNA-seq from GM12878 (ENCSR673UIY) 5.33
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.3
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.3
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 5.28
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 5.26
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 5.25
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 5.25
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 5.25
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 5.24
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 5.24
Effect of drugs on transcriptomic profiles 5.2
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 5.14
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 5.12
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 5.06
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 5.04
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 4.99
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.98
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 4.89
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 4.86
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 4.73
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.72
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 4.7
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 4.7
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 4.7
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 4.7
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 4.69
Regulation of protein translation during mitosis 4.68
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 4.66
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 4.66
Transcriptional profile in human S. haematobium infection 4.62
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 4.62
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.6
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.6
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 4.59
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 4.58
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 4.56
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 4.55
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 4.55
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 4.51
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 4.5
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 4.49
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 4.44
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 4.37
Regulation of poly(A) tail and translation during the somatic cell cycle 4.33
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 4.32
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 4.31
Role of COP1 on MAP kinase transcriptional output in melanoma 4.16
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 4.16
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 4.16
Exploring ILF2 regulatory genes by next-generation sequencing 4.15
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 4.11
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 4.11
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 4.1
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 4.1
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 4.1
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 4.06
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 4.02
The transcriptome effect of overexpressing EZH2 in MCF7 3.96
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.96
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 3.94
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 3.91
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 3.91
Human HAP1 cells before and after nutrient deprivation 3.85
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 3.85
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 3.84
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 3.84
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 3.82
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 3.82
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 3.82
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 3.79
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 3.79
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.78
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 3.77
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.74
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 3.73
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 3.73
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.7
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 3.68
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 3.68
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 3.64
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 3.62
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 3.58
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 3.5
STX4 Over-Expression in Human islets 3.5
RNA-seq analysis upon ARID1B overexpression 3.47
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.45
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 3.44
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 3.44
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 3.38
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 3.36
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 3.36
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 3.33
RNA-Seq of PRMT1 overexpression ECA109 cells 3.33
A549 cell transcriptome responses to infection with H7N9 influenza virus 3.33
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 3.31
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.31
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.28
Identification of global XBP1s target gene expression in human prostate cancer cells 3.27
The Genetic Landscape of Diamond-Blackfan Anemia 3.27
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.23
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.23
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 3.22
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.22
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.22
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.18
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 3.16
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 3.16
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.15
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 3.14
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 3.14
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 3.11
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.07
Loss of CREBBP results in gene expression repression in lymphoma cells 3.07
Hypoxic transcriptome of SQ20B human head and neck cancer cells 3.04
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 3.02
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.93
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 2.75
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.72
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 2.68
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 2.62
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 2.62
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.55
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 2.49
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.49
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 2.48
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 2.48
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.4
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 2.38
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.31
Role of cervicovaginal microbiota in genital inflammation 2.3
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.29
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.26
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 2.23
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.21
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.21
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.2
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 2.19
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 2.19
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.17
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.17
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.17
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.15
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.13
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 2.1
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.09
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.08
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.08
RNA-Seq from human ILC transitional populations 2.05
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.05
RNA sequencing with KSHV infection and enrichment for circular RNAs 2.04
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.03
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 2.0
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.0
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 2.0
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 2.0
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.0
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.95
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.94
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.92
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.9
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.84
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.82
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.8
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.79
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 1.79
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 1.79
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.78
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.76
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.76
MARCKS and lnc-MARCKS act as inflammation regulators 1.76
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 1.67
Interaction between mitoNEET and NAF-1 in cancer cells 1.63
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.61
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 1.55
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.55
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 1.53
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 1.53
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 1.51
FBXW7 modulates stress response by post-translational modification of HSF1 1.51
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.5
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.44
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 1.42
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 1.39
Aneuploidy triggers an immune response 1.39
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.39
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 1.38
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 1.34
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.33
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.31
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.29
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 1.24
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.23
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.22
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.22
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.19
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.19
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.18
Identification of HOXB13 target genes responsive to BET inhibitors 1.11
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.11
RNA-seq analysis of control and Myc-induced U2OS cells 1.1
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.05
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.04
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.03
Aging-associated patterns in the expression of human endogenous retroviruses 1.02
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.02
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.97
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 0.97
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.95
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.95
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.92
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.92
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 0.91
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 0.9
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 0.9
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.89
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.87
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.84
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.81
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.81
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.79
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.78
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.76
Transcriptome analysis of CNS leukemia 0.76
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 0.74
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.74
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.74
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 0.72
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.7
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.69
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.69
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 0.69
Ribosomal protein RPL26 is the principal target of UFMylation 0.63
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 0.61
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.58
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.53
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.51
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.51
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.5
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.5
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.5
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.5
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.5
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.49
RNA-seq data 0.49
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.47
RNA seq comparison between scrambled and shGRP78 cells 0.46
Human Treg IL-12 stimulation 0.42
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.38
BACH2 in human plasma cell fate decision 0.35
A code of mono-phosphorylation modulates the function of RB. 0.34
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.34
RNAseq of Breast cancer PDX samples 0.33
RNA-seq of MDA-MB-231 cells with TET1 knockout 0.3
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.29
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 0.26
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.25
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.25
Fusion discovery in breast cancer cell line 0.19
Preclinical model of obesity and ER-positive breast cancer 0.15
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.13
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.13
Transcriptome-wide modulation of splicing by the exon junction complex 0.11
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.09
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.09
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.09
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.09
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 0.09
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.06
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.06
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.05
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.03
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.03
Modulation of nonsense-mediated decay by rapamycin 0.02
HBEC-shp53-PCHD7 0.01
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.01
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.0
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation